It is. Let us not forget that SKTO is the mother ship.

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles SK3GURU #26675
It is. Let us not forget that SKTO is the mother ship. Allyn is Chairman of SKTO; Benz is Executive Vice President of SKTO (as well as General Legal Counsel). Allyn said, "Our goal is to be nationwide."  Benz said, "We're not in this for nickels."

As a relevant footnote, SKTO company president Mayor seemed to be telegraphing a message by using the possessive adjective "our" four times in his quoted statement  in the last press release(02/28/2014), three times in describing the Pharmajanes web platform and once describing Dharmanol.

02/28/2014 Mr. Artemus Mayor, President of SK3 Group said, "Now that our Pharmajanes site is up and running, and we are filling orders for our Dharmanol product, we are pleased to be initiating distribution for this important product through our Pharmajanes platform. While Dharmanol Citrolene will only be available to participants in the promotion for the next several weeks, we intend to have the product available to all qualified patients soon, either through our Pharmajanes platform, or through their local dispensary."
###

(Marketwired) - 02/28/14 - Medical Greens, a subsidiary of SK3 Group (OTC Pink: SKTO) is seeking qualified California medical marijuana patients to receive a free sample of its new, non-psychoactive medical cannabis product, Dharmanol Citrolene, developed by its Berkeley Bio-Organic Research Laboratory.

Containing many of the medicinal elements of medical marijuana in their non-psychoactive form, Dharmanol Citrolene provides many of the benefits that scientists are ascribing to medical cannabis, without the high associated with eating or smoking marijuana.

Dharmanol Citrolene contains CBD, a non-psychoactive "chemical cousin" to THC, the element in marijuana that makes people high or stoned. In addition, it contains phyto-cannabinoids in their non-psychoactive carboxylate form. It also contains d-limonene, a medicinal element found in cannabis, known as a terpene.

D-limonene has been shown to have a relaxing, anti-anxiety, anti-spasmodic effect. This is because it binds to the same receptors in the human body as do the pharmaceutical synthetics Valium and Xanax. Dharmanol Citrolene contains a healthy dose of organically-sourced d-limonene. Although the d-limonene used in Dharmanol Citrolene is chemically identical to that produced by the cannabis/hemp plant, it is actually sourced from the rind of citrus fruits.

Interestingly, research has shown d-limonene to have many properties that are similar to cannabis in their interaction with cancer. Sloan Kettering Cancer Center lists 19 very promising studies using this powerful natural medicine.
mskcc.org/cancer-care/herb/d-limonene

To participate in the Company's survey, an individual must be a medical cannabis patient with a valid physician recommendation and live in the State of California in one of the zip codes currently served by Pharmajanes.com. To see if you qualify, go to the website and check out the section labeled "Dharmanol Citrolene Promotion." Starting this upcoming Wednesday, March 5, 2014, individuals requesting the promotional product during the first 30 days, while supplies last, will receive a 2-pack of the product.
Patients participating in the survey will be asked to complete a short questionnaire about their use of the product which will assist the Company in developing or improving its offerings.

Dharmanol Citrolene will be available for sale soon after that through Pharmajanes and many dispensaries throughout California.

Mr. Artemus Mayor, President of SK3 Group said, "Now that our Pharmajanes site is up and running, and we are filling orders for our Dharmanol product, we are pleased to be initiating distribution for this important product through our Pharmajanes platform. While Dharmanol Citrolene will only be available to participants in the promotion for the next several weeks, we intend to have the product available to all qualified patients soon, either through our Pharmajanes platform, or through their local dispensary."

About AEGY
PharmaJanes is an online ordering platform allowing medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes also is the exclusive online marketing platform for Medical Greens, a subsidiary of SK3 Group, Inc. (OTC Pink: SKTO).

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.



SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Unraveling Quantum BioPharma’s $700 Million Legal Battle

Updated Category News Views 154

Quantum BioPharma's $700 Million Lawsuit TORONTO, Quantum BioPharma Ltd. (NASDAQ: QNTM) has recently gained significant attention following its announcement of a major lawsuit against two of Canada's largest banks. This lawsuit, totaling USD $700 million, revolves around the allegation of stock market manipulation, a serious issue for any company trying to navigate the...

Continue Reading
Empowering Industrial Growth in China Through E-Commerce Events

Updated Category News Views 104

Boosting Industrial Growth Through E-Commerce A recent salon event aimed at promoting industrial development through cross-border e-commerce was held in Changsha County. This gathering highlighted the need to establish a clear pathway for developing industrial belts at the county level. Gathering of Industry Leaders The event attracted more than 100 representatives from a...

Continue Reading
Central Garden & Pet Reports Improved Q4 Earnings Results

Updated Category News Views 97

Central Garden & Pet's Q4 Earnings Highlights Central Garden & Pet (NASDAQ: CENT) has recently released its Q4 earnings report, providing valuable insights into its financial performance. Despite facing challenges, the company's latest results demonstrate resilience and potential for growth. Earnings Performance In the latest quarter, Central Garden & Pet exceeded...

Continue Reading
Shanghai Furniture Show Guides European Buyers' Hunt

Updated Category News Views 15

European Buyers' Shanghai Pilgrimage Here's what's cooking in the sizzling world of furniture trade: come September, the focus shifts to Shanghai—the heart of Asia's manufacturing prowess. Furniture China and Maison Shanghai 2026 are gearing up to host a who's who of European retailers, distributors, importers, and designers for a duo of shows that promise an immersive...

Continue Reading
Perle Expands into Solana Ecosystem for AI Advancement

Updated Category News Views 226

Perle Joins the Solana Ecosystem to Enhance AI Development Perle, an innovative AI training data platform, has made a significant move by integrating into the Solana ecosystem. This aims to bridge human intelligence with AI models, a crucial aspect of improving AI systems. The integration signifies a pivotal moment for Perle as it aspires to enhance AI's overall training...

Continue Reading